Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma

scientific article published on 20 September 2018

Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41379-018-0131-6
P698PubMed publication ID30237525

P50authorCharles Y. ChiuQ30505278
Kuang-Yu JenQ59691146
Kirk D JonesQ74054359
Soo-Jin ChoQ80421609
Eliah R ShamirQ82567506
Sarah E UmetsuQ88161586
Melike PekmezciQ88683629
P2093author name stringSanjay Kakar
Scot Federman
Emily Bergsland
Grace E Kim
Nancy M Joseph
Gregor Krings
W Patrick Devine
Tara A Saunders
P2860cites workDELLY: structural variant discovery by integrated paired-end and split-read analysisQ24605418
Gastroenteropancreatic high-grade neuroendocrine carcinomaQ26998392
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.Q27853379
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataQ27860742
The Sequence Alignment/Map format and SAMtoolsQ27860966
Exonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replicationQ28248149
PD-1 Blockade in Tumors with Mismatch-Repair DeficiencyQ28262647
Fast and accurate long-read alignment with Burrows-Wheeler transformQ29547193
A framework for variation discovery and genotyping using next-generation DNA sequencing dataQ29547262
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Q29547773
Papillomaviruses and cancer: from basic studies to clinical applicationQ29614745
Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancerQ29615679
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short readsQ29617402
Pembrolizumab in cervical cancer: latest evidence and clinical usefulnessQ33757149
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.Q34202062
Human papillomavirus is not associated with colorectal cancer in a large international studyQ34723700
Human papillomavirus-related small cell carcinoma of the oropharynxQ35354701
Neuroendocrine carcinomas of the colon and rectum.Q35713624
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing.Q35995950
Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR.Q36479375
RB and cell cycle progressionQ36579245
Comprehensive genomic profiles of small cell lung cancerQ36883530
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancerQ36951751
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine CarcinomasQ37182620
The evolving landscape of neuroendocrine tumorsQ38079850
The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomasQ38079856
Automated Extraction of Formalin-Fixed, Paraffin-Embedded Tissue for High-Risk Human Papillomavirus Testing of Head and Neck Squamous Cell Carcinomas Using the Roche Cobas 4800 SystemQ38381324
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicineQ38605559
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerQ38768101
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the PancreasQ38853033
Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomasQ39036665
In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components.Q39430735
Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel DiseaseQ40808084
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC studyQ43905778
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical PathologyQ46864354
Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.Q47358369
Biology and evolution of poorly differentiated neuroendocrine tumorsQ48320507
HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behaviorQ48678604
Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signalingQ49283122
Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.Q50652349
Whole-genome landscape of pancreatic neuroendocrine tumours.Q51137102
Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor.Q52664181
Small-cell neuroendocrine carcinoma of the cervix. A human papillomavirus type 18-associated cancerQ67912069
Detection of human papillomavirus in small cell carcinomas of the anus and rectumQ83983234
The genetics of neuroendocrine tumorsQ86078968
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic StratificationQ89256994
P433issue2
P921main subjectneuroendocrine carcinomaQ18554913
P304page(s)290-305
P577publication date2018-09-20
P1433published inModern PathologyQ15724578
P1476titleIdentification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma
P478volume32

Reverse relations

cites work (P2860)
Q92132897A novel group of HPV-related adenocarcinomas of the lower anogenital tract (vagina, vulva, and anorectum) in women and men resembling HPV-related endocervical adenocarcinomas
Q90604719An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin
Q90706027Cancer stem cells in esophageal squamous cell cancer
Q64949324Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review.
Q98665207Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine
Q91752429The broken cycle: E2F dysfunction in cancer